David R. Croucher
@davidrcroucher.bsky.social
Cancer, Systems Biology and Drug Discovery Researcher | Laboratory Head - Garvan Institute | Assoc. Professor - UNSW
Excited to see our work on overcoming drug resistance in relapsed high-risk neuroblastoma out there! Huge collaboration with the good people at the Children's Cancer Institute and @sysbioire.bsky.social:
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma
Drug combinations using differential apoptotic components can overcome the impaired state of relapsed high-risk neuroblastoma.
www.science.org
November 30, 2025 at 10:24 PM
Excited to see our work on overcoming drug resistance in relapsed high-risk neuroblastoma out there! Huge collaboration with the good people at the Children's Cancer Institute and @sysbioire.bsky.social:
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...